A healthier world needs a strong foundation – one that establishes quality, sets the bar for scientific rigor and technological progress, and epitomizes collaboration between industry, nonprofits, government and academia.
From the standards we create to the partnerships and conversations we foster, our scientists, advocates and network of experts are critical to constructing and reinforcing this foundation to ensure people stay healthy.
Latest Standards Updates
USP-NF
Two New Revision Bulletins (posted 28–Dec–2018)
Two New Pending Notices of Intent to Revise (posted 28–Dec–2018, 13–Dec–2018)
Two Updated Notices of Intent to Revise (posted 28–Dec–2018)
Cumulative List Updated (posted 28–Dec–2018)
Reference Standards
UPDATE: USP Nystatin Reference Standard Customer Support Guidance (01–May–2017)
Reference Standards Under Development List (updated quarterly)
Quality Matters Blog
Poor-quality medicines receives little attention in public health policy discussions. However it puts millions of lives at risk, costs economies billions of dollars and undermines decades of hard-earned health progress.
Building the marketplace for generic medicines is a key strategy to containing drug costs in the US, one that USP actively supports through our standards-setting work.
As digital therapies represent an emerging science that can offer exciting alternatives for some patients, it is important to ask how the quality of these therapies can be assured.